克罗地亚 - 克罗地亚文 - HALMED (Agencija za lijekove i medicinske proizvode)

viatris limited, damastown industrial park, mulhuddart, dublin, irska - paracetamol - tableta - 1000 mg - urbroj: jedna tableta sadrži 1000 mg paracetamola

克罗地亚 - 克罗地亚文 - HALMED (Agencija za lijekove i medicinske proizvode)

viatris limited, damastown industrial park, mulhuddart, dublin, irska - paracetamol - tableta - 500 mg - urbroj: jedna tableta sadrži 500 mg paracetamola

克罗地亚 - 克罗地亚文 - HALMED (Agencija za lijekove i medicinske proizvode)

viatris limited, damastown industrial park, mulhuddart, dublin, irska - nitrofurantoin - kapsula, tvrda - urbroj: svaka kapsula sadrži 50 mg nitrofurantoina (u makrokristalnom obliku).

欧盟 - 克罗地亚文 - EMA (European Medicines Agency)

mylan ireland limited - rivaroksaban - venous thromboembolism; pulmonary embolism; acute coronary syndrome; stroke; coronary artery disease; peripheral arterial disease; atrial fibrillation - antitrombotska sredstva - rivaroxaban mylan co-administered with acetylsalicylic acid (asa) alone or with asa plus clopidogrel or ticlopidine, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (acs) with elevated cardiac biomarkers.  rivaroxaban mylan co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events.  ------prevention of venous thromboembolism (vte) in adult patients undergoing elective hip or knee replacement surgery.  treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults. -------adults prevention of stroke and systemic embolism in adult   patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.

欧盟 - 克罗地亚文 - EMA (European Medicines Agency)

mylan pharmaceuticals limited - memantin hidroklorid - alzheimerova bolest - other anti-dementia drugs, psychoanaleptics, - liječenje bolesnika s umjerenom ili teškom alzheimerovom bolesti.

克罗地亚 - 克罗地亚文 - HALMED (Agencija za lijekove i medicinske proizvode)

viatris limited, damastown industrial park, mulhuddart, dublin, irska - apiksaban - filmom obložena tableta - urbroj: jedna filmom obložena tableta sadrži 5 mg apiksabana

欧盟 - 克罗地亚文 - EMA (European Medicines Agency)

mylan ire healthcare limited - fondaparinux natrij - venous thrombosis; pulmonary embolism; myocardial infarction; angina, unstable - antitrombotska sredstva - 5 mg / 0. 3 ml i 2. 5 mg / 0. 5-ml solution for injectionprevention of venous thromboembolic events (vte) in adults undergoing major orthopaedic surgery of the lower limbs such as hip fracture, major knee surgery or hip-replacement surgery. prevencija ВТЭ kod odraslih pacijenata koji su patili operacija na organima trbušne šupljine, koje se smatraju s visokim rizikom тромбоэмболических komplikacija, kao što su pacijenti izložena abdominalnu kirurgiju raka. prevencija ВТЭ kod odraslih pacijenata zdravstvenim ustanovama, za koje se smatra da su na visokim rizikom od ВТЭ i koji обездвижены zbog akutne bolesti kao što su zatajenje srca i / ili akutnim problemima respiratornih bolesti i / ili akutne zarazne ili upalne bolesti. tretman za odrasle osobe s oštrim симптоматическим spontani površni тромбозом vena donjih ekstremiteta bez kolateralne tromboze dubokih vena. 5 mg / 0. 5-ml solution for injectiontreatment of unstable angina or non-st-segment-elevation myocardial infarction (ua/nstemi) in adult patients for whom urgent (< 120 mins) invasive management (pci) is not indicated. srčani udar (infarkt miokarda) kod odraslih pacijenata, koji se upravlja pomoću тромболитиков ili koji je u početku trebao primati nikakve druge oblike terapije реперфузионной. 5 mg / 0. 4 ml, 7. 5 mg / 0. 6-ml i 10 mg/0. 8-ml solution for injectiontreatment of adults with acute deep-vein thrombosis (dvt) and treatment of acute pulmonary embolism (pe), except in haemodynamically unstable patients or patients who require thrombolysis or pulmonary embolectomy.

克罗地亚 - 克罗地亚文 - HALMED (Agencija za lijekove i medicinske proizvode)

viatris limited, damastown industrial park, mulhuddart, dublin, irska - solifenacinsukcinat - filmom obložena tableta - 10 mg - urbroj: svaka filmom obložena tableta sadrži 10 mg solifenacinsukcinata, što odgovara 7,5 mg solifenacina

克罗地亚 - 克罗地亚文 - HALMED (Agencija za lijekove i medicinske proizvode)

viatris limited, damastown industrial park, mulhuddart, dublin, irska - solifenacinsukcinat - filmom obložena tableta - 5 mg - urbroj: svaka filmom obložena tableta sadrži 5 mg solifenacinsukcinata, što odgovara 3,8 mg solifenacina

克罗地亚 - 克罗地亚文 - HALMED (Agencija za lijekove i medicinske proizvode)

viatris limited, damastown industrial park, mulhuddart, dublin, irska - rosuvastatinkalcij - filmom obložena tableta - 10 mg - urbroj: jedna filmom obložena tableta sadrži 10 mg rosuvastatina (u obliku rosuvastatinkalcija)